Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ecopetrol SA (EC) vs Johnson & Johnson (JNJ) Price & Performance

Ecopetrol SATrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Ecopetrol SA vs Johnson & Johnson — how do they compare? Ecopetrol SA trades at $17 (market cap $34.97B), while Johnson & Johnson trades at $259.44 (market cap $630.94B). The key difference: Johnson & Johnson is far larger — about 18× Ecopetrol SA's market cap, and Ecopetrol SA pays the higher dividend (3.81%). Which is the better fit depends on your goals.

ECJNJ
Market Cap
$34.97B$630.94B
Sector
EnergyHealth
52-Week High
$17.40$267.24
52-Week Low
$8.56$172.78
Enterprise Value
$65.28B$659.21B
Dividend Yield
3.81%2.05%
Volume
6,156,228

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ecopetrol SA

Ecopetrol (EC) trades at $16.78, down 3.56% on the day, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators are neutral. Fundamentally, revenue and net income have declined from 2022 peaks, though Q2 2026 earnings beat expectations. Recent news includes a cybersecurity incident and expansion efforts in Brazil, adding to volatility. Valuation ratios like P/E of 11.11 and P/S of 0.97 suggest potential undervaluation relative to historical metrics.

The outlook for EC is cautious; analyst consensus is mixed with a $15 price target below the current price. Risks include declining revenue trends, high debt levels, and operational disruptions from recent cyber threats. Opportunities lie in cost management and strategic acquisitions, but investor sentiment remains divided. The stock's near-term performance hinges on execution stability and energy market conditions.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $259.24, up 0.88% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $282.33. Recent earnings beat expectations in Q1 and Q2 2026, with Q3 results pending. The company maintains strong profitability, including a 67.91% gross margin and 21.48% net income margin, supported by consistent dividend payments, including a recent $1.34 per share payout.

JNJ offers stability with a 64-year dividend growth streak and robust fundamentals, but risks include rising debt-to-asset ratios (24.06% in 2025) and sector volatility. Upside potential hinges on execution of growth initiatives and healthcare market dynamics, with analysts favoring a buy rating (52.5% consensus).

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ecopetrol SA

Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.

Read more on EC

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ